Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2

Oncogene
A HoggThomas J Gonda

Abstract

Primary murine fetal hemopoietic cells were transformed with a fusion protein consisting of the ligand-binding domain of the estrogen receptor and a carboxyl-terminally truncated c-Myb protein (ERMYB). The ERMYB-transformed hemopoietic cells exhibit an immature myeloid phenotype when grown in the presence of beta-estradiol. Upon removal of beta-estradiol, the ERMYB cells display increased adherence, decreased clonogenicity and differentiate to cells exhibiting granulocyte or macrophage morphology. The expression of the c-myc, c-kit, cdc2 and bcl-2 genes, which are putatively regulated by Myb, was investigated in ERMYB cells grown in the presence or absence of beta-estradiol. Neither c-myc nor cdc2 expression was down-regulated after removal of beta-estradiol demonstrating that differentiation is not a consequence of decreased transactivation of these genes by ERMYB. While bcl-2 expression was reduced by 50% in ERMYB cells grown in the absence of beta-estradiol, there was no increase in DNA laddering, suggesting that Myb was not protecting ERMYB cells from apoptosis. In contrast, a substantial (200-fold) decrease in c-kit mRNA level was observed following differentiation of ERMYB cells, and c-kit mRNA could be partially re-induc...Continue Reading

Citations

Mar 18, 2008·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Santhosh GirirajanSarah H Elsea
Jul 27, 2001·Biochimica Et Biophysica Acta·U SchlichterK H Klempnauer
Oct 19, 1999·Biochimica Et Biophysica Acta·O Burk, K H Klempnauer
Apr 8, 1998·Current Opinion in Genetics & Development·K Weston
Sep 16, 2003·Blood Cells, Molecules & Diseases·Scott A Ness
Dec 3, 1999·The International Journal of Biochemistry & Cell Biology·L K Ashman
Dec 17, 2004·Molecular and Cellular Biology·Olesya ChaykaKarl-Heinz Klempnauer
Feb 18, 2006·Blood·Alexandros VegiopoulosJon Frampton
Sep 8, 2007·BMC Molecular Biology·Holger GundelachKarl-Heinz Klempnauer
Oct 16, 2010·PloS One·Aaron R ThornerCharles M Perou
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Ye Zhou, Scott A Ness
Jul 2, 2009·Reproduction : the Official Journal of the Society for the Study of Fertility·Sridurga Mithraprabhu, Kate L Loveland
Jul 1, 2008·Seminars in Immunology·Kylie T GreigStephen L Nutt
May 16, 2008·Blood Cells, Molecules & Diseases·Liang ZhaoThomas J Gonda
Mar 22, 2008·Biochemical and Biophysical Research Communications·Brent NeumannThomas J Gonda
May 3, 2006·Biochemical and Biophysical Research Communications·Jodi K LutwycheThomas J Gonda
Mar 22, 2001·Blood Cells, Molecules & Diseases·P A BartleyT J Gonda
Oct 19, 1999·Oncogene·M ZorbasR G Ramsay
Jun 26, 2002·Oncogene·Hartmut Appl, Karl-Heinz Klempnauer
Jun 15, 2004·Oncogene·Jörg KintscherKarl-Heinz Klempnauer
Apr 21, 2001·Oncogene·U SchlichterK H Klempnauer
Apr 24, 2004·The Journal of Biological Chemistry·Wanli LeiScott A Ness
Dec 21, 2004·Oncogene·Georgina LangKathleen Weston
Oct 22, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shawn P FahlTimothy P Bender

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis